

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of thymocyte apoptotic process (GO:0070243) | 8.85806284 |
| 2 | positive regulation of gamma-delta T cell activation (GO:0046645) | 8.85462853 |
| 3 | mucosal-associated lymphoid tissue development (GO:0048537) | 8.74115974 |
| 4 | Peyers patch development (GO:0048541) | 8.74115974 |
| 5 | activated T cell proliferation (GO:0050798) | 8.04249762 |
| 6 | positive T cell selection (GO:0043368) | 7.88293044 |
| 7 | negative regulation of T cell apoptotic process (GO:0070233) | 7.50330960 |
| 8 | T cell selection (GO:0045058) | 7.07058833 |
| 9 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 6.96091673 |
| 10 | positive regulation of calcium-mediated signaling (GO:0050850) | 6.91891140 |
| 11 | modulation by virus of host process (GO:0019054) | 6.81733866 |
| 12 | T cell receptor signaling pathway (GO:0050852) | 6.78709181 |
| 13 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 6.66427820 |
| 14 | genitalia morphogenesis (GO:0035112) | 6.53547692 |
| 15 | regulation of regulatory T cell differentiation (GO:0045589) | 6.52607490 |
| 16 | somatic cell DNA recombination (GO:0016444) | 6.47169449 |
| 17 | somatic diversification of immune receptors via germline recombination within a single locus (GO:000 | 6.47169449 |
| 18 | negative T cell selection (GO:0043383) | 6.41424352 |
| 19 | T cell differentiation in thymus (GO:0033077) | 6.38552591 |
| 20 | cellular hyperosmotic response (GO:0071474) | 6.07421890 |
| 21 | T cell differentiation (GO:0030217) | 6.03580197 |
| 22 | positive regulation of interleukin-2 production (GO:0032743) | 5.86070911 |
| 23 | somatic diversification of immune receptors (GO:0002200) | 5.82808790 |
| 24 | modulation by symbiont of host cellular process (GO:0044068) | 5.65365780 |
| 25 | alpha-beta T cell differentiation (GO:0046632) | 5.47847211 |
| 26 | T cell costimulation (GO:0031295) | 5.34777027 |
| 27 | T cell mediated immunity (GO:0002456) | 5.26465685 |
| 28 | lymphocyte costimulation (GO:0031294) | 5.23003998 |
| 29 | antigen receptor-mediated signaling pathway (GO:0050851) | 5.14447567 |
| 30 | mast cell activation involved in immune response (GO:0002279) | 5.07399974 |
| 31 | mast cell degranulation (GO:0043303) | 5.07399974 |
| 32 | negative regulation of lymphocyte apoptotic process (GO:0070229) | 5.07320207 |
| 33 | alpha-beta T cell activation (GO:0046631) | 5.02140266 |
| 34 | regulation of defense response to virus by virus (GO:0050690) | 4.91765199 |
| 35 | regulation of calcium-mediated signaling (GO:0050848) | 4.68971898 |
| 36 | regulation of interleukin-2 production (GO:0032663) | 4.56806651 |
| 37 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 4.56525573 |
| 38 | mast cell activation (GO:0045576) | 4.46389048 |
| 39 | generation of neurons (GO:0048699) | 4.31430143 |
| 40 | regulation of T cell receptor signaling pathway (GO:0050856) | 4.30208195 |
| 41 | regulation of T cell apoptotic process (GO:0070232) | 4.27183991 |
| 42 | T cell lineage commitment (GO:0002360) | 4.26081691 |
| 43 | CD4-positive, alpha-beta T cell differentiation (GO:0043367) | 4.14498548 |
| 44 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.00040465 |
| 45 | T cell activation (GO:0042110) | 3.97590423 |
| 46 | positive regulation of uterine smooth muscle contraction (GO:0070474) | 3.91990227 |
| 47 | T cell homeostasis (GO:0043029) | 3.88826085 |
| 48 | zinc ion homeostasis (GO:0055069) | 3.84249866 |
| 49 | lymphocyte differentiation (GO:0030098) | 3.76351482 |
| 50 | positive thymic T cell selection (GO:0045059) | 3.72948404 |
| 51 | positive regulation of histone H3-K4 methylation (GO:0051571) | 3.72710889 |
| 52 | CD4-positive, alpha-beta T cell activation (GO:0035710) | 3.70200873 |
| 53 | entry into other organism involved in symbiotic interaction (GO:0051828) | 3.69827502 |
| 54 | movement in host environment (GO:0052126) | 3.69827502 |
| 55 | entry into host cell (GO:0030260) | 3.69827502 |
| 56 | movement in environment of other organism involved in symbiotic interaction (GO:0052192) | 3.69827502 |
| 57 | entry into cell of other organism involved in symbiotic interaction (GO:0051806) | 3.69827502 |
| 58 | entry into host (GO:0044409) | 3.69827502 |
| 59 | negative regulation of leukocyte apoptotic process (GO:2000107) | 3.63443759 |
| 60 | histone H3-K9 demethylation (GO:0033169) | 3.58181618 |
| 61 | histone monoubiquitination (GO:0010390) | 3.57837910 |
| 62 | cellular zinc ion homeostasis (GO:0006882) | 3.55290004 |
| 63 | thymus development (GO:0048538) | 3.54059598 |
| 64 | histone H4 deacetylation (GO:0070933) | 3.48927185 |
| 65 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.48021279 |
| 66 | histone H3-K4 trimethylation (GO:0080182) | 3.39798454 |
| 67 | modulation by virus of host morphology or physiology (GO:0019048) | 3.39729673 |
| 68 | regulation of T cell differentiation (GO:0045580) | 3.39247541 |
| 69 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 3.39211328 |
| 70 | cellular response to sterol (GO:0036315) | 3.37489884 |
| 71 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.35199456 |
| 72 | negative regulation of cell killing (GO:0031342) | 3.35199456 |
| 73 | cellular response to osmotic stress (GO:0071470) | 3.31713659 |
| 74 | positive regulation of histone deacetylation (GO:0031065) | 3.29304156 |
| 75 | lymphocyte homeostasis (GO:0002260) | 3.22247196 |
| 76 | negative thymic T cell selection (GO:0045060) | 3.21709771 |
| 77 | T-helper cell differentiation (GO:0042093) | 3.20479287 |
| 78 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 3.20479287 |
| 79 | neurotransmitter catabolic process (GO:0042135) | 3.19153663 |
| 80 | lymph node development (GO:0048535) | 3.15545156 |
| 81 | regulation of histone H3-K4 methylation (GO:0051569) | 3.13080232 |
| 82 | regulation of uterine smooth muscle contraction (GO:0070472) | 3.11216950 |
| 83 | positive regulation of circadian rhythm (GO:0042753) | 3.10206749 |
| 84 | establishment of integrated proviral latency (GO:0075713) | 3.02144305 |
| 85 | thymic T cell selection (GO:0045061) | 3.00359655 |
| 86 | positive regulation of T cell activation (GO:0050870) | 2.98869770 |
| 87 | positive regulation of T cell differentiation (GO:0045582) | 2.98277738 |
| 88 | positive regulation of gene expression, epigenetic (GO:0045815) | 2.97219421 |
| 89 | regulation of T cell activation (GO:0050863) | 2.94079123 |
| 90 | DNA ligation (GO:0006266) | 2.89658535 |
| 91 | regulation of chromatin silencing (GO:0031935) | 2.83679980 |
| 92 | interferon-gamma production (GO:0032609) | 2.83128378 |
| 93 | regulation of lymphocyte apoptotic process (GO:0070228) | 2.81514863 |
| 94 | leukocyte homeostasis (GO:0001776) | 2.80043798 |
| 95 | positive regulation of intracellular steroid hormone receptor signaling pathway (GO:0033145) | 2.76877561 |
| 96 | peptidyl-lysine dimethylation (GO:0018027) | 2.74298372 |
| 97 | negative regulation of thymocyte apoptotic process (GO:0070244) | 15.7840530 |
| 98 | V(D)J recombination (GO:0033151) | 14.2840433 |
| 99 | regulation of gamma-delta T cell differentiation (GO:0045586) | 12.6110139 |
| 100 | regulation of gamma-delta T cell activation (GO:0046643) | 11.3099179 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 6.78575888 |
| 2 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.58088074 |
| 3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.51112120 |
| 4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.59524812 |
| 5 | MYC_22102868_ChIP-Seq_BL_Human | 4.58356854 |
| 6 | RUNX_20019798_ChIP-Seq_JUKART_Human | 4.01801130 |
| 7 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 3.65751015 |
| 8 | MYB_26560356_Chip-Seq_TH2_Human | 3.50040173 |
| 9 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.37009832 |
| 10 | UTX_26944678_Chip-Seq_JUKART_Human | 3.35589276 |
| 11 | TCF7_22412390_ChIP-Seq_EML_Mouse | 3.21132186 |
| 12 | GATA3_27048872_Chip-Seq_THYMUS_Human | 3.18747727 |
| 13 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.99882870 |
| 14 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.88386012 |
| 15 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.81730607 |
| 16 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.68346197 |
| 17 | MAF_26560356_Chip-Seq_TH1_Human | 2.59053197 |
| 18 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.48790158 |
| 19 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.33358762 |
| 20 | MYB_26560356_Chip-Seq_TH1_Human | 2.27150691 |
| 21 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.23032449 |
| 22 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.18978640 |
| 23 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.18857880 |
| 24 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.15464776 |
| 25 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.09813176 |
| 26 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.05053676 |
| 27 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 2.00378915 |
| 28 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.91163254 |
| 29 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.82318142 |
| 30 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.80920131 |
| 31 | TCF12/HEB_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.68357552 |
| 32 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.61396899 |
| 33 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.60014211 |
| 34 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.59161108 |
| 35 | MAF_26560356_Chip-Seq_TH2_Human | 1.56690286 |
| 36 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.53329847 |
| 37 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.49342221 |
| 38 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.45332502 |
| 39 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.44320205 |
| 40 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.35884273 |
| 41 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.33514152 |
| 42 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.29556818 |
| 43 | SPI1_23127762_ChIP-Seq_K562_Human | 1.28340122 |
| 44 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.26910194 |
| 45 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.26887938 |
| 46 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.26669203 |
| 47 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.25414179 |
| 48 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.19868776 |
| 49 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.16522647 |
| 50 | GATA2_19941826_ChIP-Seq_K562_Human | 1.10645802 |
| 51 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.10468200 |
| 52 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09706260 |
| 53 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.07919238 |
| 54 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.07262235 |
| 55 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.05842251 |
| 56 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.03679538 |
| 57 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.02940218 |
| 58 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.00462153 |
| 59 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.99673090 |
| 60 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.99588512 |
| 61 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.99364589 |
| 62 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.99236300 |
| 63 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.99137886 |
| 64 | GATA1_19941826_ChIP-Seq_K562_Human | 0.98911224 |
| 65 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.98882347 |
| 66 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.98878566 |
| 67 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.98482892 |
| 68 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.98238324 |
| 69 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.96222068 |
| 70 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 0.95497498 |
| 71 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.95461685 |
| 72 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.94668530 |
| 73 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.93275219 |
| 74 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.92987465 |
| 75 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.92018755 |
| 76 | KDM2B_26808549_Chip-Seq_K562_Human | 0.91840354 |
| 77 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.90162279 |
| 78 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.88583710 |
| 79 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.88143977 |
| 80 | GATA3_26560356_Chip-Seq_TH2_Human | 0.87297364 |
| 81 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.86806584 |
| 82 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.83414317 |
| 83 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.82482246 |
| 84 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.80944485 |
| 85 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.80605630 |
| 86 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.78835159 |
| 87 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.78769214 |
| 88 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.78322294 |
| 89 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.78003562 |
| 90 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.77996591 |
| 91 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.77865670 |
| 92 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.75728509 |
| 93 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.75721741 |
| 94 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.75599559 |
| 95 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.75232295 |
| 96 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.74149115 |
| 97 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.73894823 |
| 98 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 0.73617038 |
| 99 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.73065698 |
| 100 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.72816248 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005409_darkened_coat_color | 5.63434842 |
| 2 | MP0003763_abnormal_thymus_physiology | 5.19998188 |
| 3 | MP0002132_abnormal_respiratory_system | 4.69889538 |
| 4 | MP0002166_altered_tumor_susceptibility | 4.64710620 |
| 5 | MP0001849_ear_inflammation | 4.18294372 |
| 6 | MP0005671_abnormal_response_to | 4.18238363 |
| 7 | MP0000703_abnormal_thymus_morphology | 3.98147330 |
| 8 | MP0009278_abnormal_bone_marrow | 3.73738867 |
| 9 | MP0002006_tumorigenesis | 3.45319237 |
| 10 | MP0004947_skin_inflammation | 3.22381971 |
| 11 | MP0010155_abnormal_intestine_physiology | 2.84003175 |
| 12 | MP0000015_abnormal_ear_pigmentation | 2.77235766 |
| 13 | MP0005365_abnormal_bile_salt | 2.75935191 |
| 14 | MP0005174_abnormal_tail_pigmentation | 2.73461288 |
| 15 | MP0006082_CNS_inflammation | 2.51601592 |
| 16 | MP0009785_altered_susceptibility_to | 2.50877194 |
| 17 | MP0000685_abnormal_immune_system | 2.41704421 |
| 18 | MP0010094_abnormal_chromosome_stability | 2.38927447 |
| 19 | MP0002876_abnormal_thyroid_physiology | 2.34456786 |
| 20 | MP0002095_abnormal_skin_pigmentation | 2.32294527 |
| 21 | MP0004130_abnormal_muscle_cell | 2.20485481 |
| 22 | MP0001879_abnormal_lymphatic_vessel | 2.12503628 |
| 23 | MP0002398_abnormal_bone_marrow | 2.08463436 |
| 24 | MP0005397_hematopoietic_system_phenotyp | 2.01973407 |
| 25 | MP0001545_abnormal_hematopoietic_system | 2.01973407 |
| 26 | MP0002722_abnormal_immune_system | 1.98381273 |
| 27 | MP0000920_abnormal_myelination | 1.92578112 |
| 28 | MP0004808_abnormal_hematopoietic_stem | 1.79343689 |
| 29 | MP0002933_joint_inflammation | 1.69196362 |
| 30 | MP0000716_abnormal_immune_system | 1.60307419 |
| 31 | MP0001790_abnormal_immune_system | 1.58627634 |
| 32 | MP0005387_immune_system_phenotype | 1.58627634 |
| 33 | MP0003879_abnormal_hair_cell | 1.54146310 |
| 34 | MP0000689_abnormal_spleen_morphology | 1.52860232 |
| 35 | MP0002405_respiratory_system_inflammati | 1.51578643 |
| 36 | MP0000462_abnormal_digestive_system | 1.47223966 |
| 37 | MP0001835_abnormal_antigen_presentation | 1.44449009 |
| 38 | MP0003300_gastrointestinal_ulcer | 1.41188501 |
| 39 | MP0009333_abnormal_splenocyte_physiolog | 1.40258221 |
| 40 | MP0001800_abnormal_humoral_immune | 1.39697848 |
| 41 | MP0002075_abnormal_coat/hair_pigmentati | 1.36910126 |
| 42 | MP0002420_abnormal_adaptive_immunity | 1.32499932 |
| 43 | MP0001819_abnormal_immune_cell | 1.30111108 |
| 44 | MP0002723_abnormal_immune_serum | 1.25439148 |
| 45 | MP0005000_abnormal_immune_tolerance | 1.23504282 |
| 46 | MP0002429_abnormal_blood_cell | 1.19620952 |
| 47 | MP0006035_abnormal_mitochondrial_morpho | 1.14012936 |
| 48 | MP0003959_abnormal_lean_body | 1.10138070 |
| 49 | MP0005025_abnormal_response_to | 1.08067485 |
| 50 | MP0008961_abnormal_basal_metabolism | 1.07651061 |
| 51 | MP0001243_abnormal_dermal_layer | 1.07622292 |
| 52 | MP0008569_lethality_at_weaning | 1.04596359 |
| 53 | MP0001191_abnormal_skin_condition | 1.03440292 |
| 54 | MP0002971_abnormal_brown_adipose | 0.99065944 |
| 55 | MP0001186_pigmentation_phenotype | 0.95699573 |
| 56 | MP0005076_abnormal_cell_differentiation | 0.95289391 |
| 57 | MP0001845_abnormal_inflammatory_respons | 0.95013414 |
| 58 | MP0000383_abnormal_hair_follicle | 0.92385455 |
| 59 | MP0008770_decreased_survivor_rate | 0.90587738 |
| 60 | MP0000490_abnormal_crypts_of | 0.88464697 |
| 61 | MP0005464_abnormal_platelet_physiology | 0.86452185 |
| 62 | MP0003787_abnormal_imprinting | 0.83523157 |
| 63 | MP0002452_abnormal_antigen_presenting | 0.79409061 |
| 64 | MP0010678_abnormal_skin_adnexa | 0.78659140 |
| 65 | MP0000609_abnormal_liver_physiology | 0.74161272 |
| 66 | MP0004859_abnormal_synaptic_plasticity | 0.68350992 |
| 67 | MP0002019_abnormal_tumor_incidence | 0.68176251 |
| 68 | MP0002396_abnormal_hematopoietic_system | 0.67955756 |
| 69 | MP0002092_abnormal_eye_morphology | 0.66621286 |
| 70 | MP0002160_abnormal_reproductive_system | 0.65134946 |
| 71 | MP0002970_abnormal_white_adipose | 0.63477413 |
| 72 | MP0002148_abnormal_hypersensitivity_rea | 0.62216234 |
| 73 | MP0002083_premature_death | 0.60987581 |
| 74 | MP0002998_abnormal_bone_remodeling | 0.59231588 |
| 75 | MP0002127_abnormal_cardiovascular_syste | 0.56033489 |
| 76 | MP0002060_abnormal_skin_morphology | 0.55627826 |
| 77 | MP0010352_gastrointestinal_tract_polyps | 0.55197943 |
| 78 | MP0009115_abnormal_fat_cell | 0.53967293 |
| 79 | MP0005360_urolithiasis | 0.53625640 |
| 80 | MP0000367_abnormal_coat/_hair | 0.52696183 |
| 81 | MP0006054_spinal_hemorrhage | 0.52434553 |
| 82 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.51347315 |
| 83 | MP0000477_abnormal_intestine_morphology | 0.50079655 |
| 84 | MP0005334_abnormal_fat_pad | 0.49276864 |
| 85 | MP0002009_preneoplasia | 0.47446665 |
| 86 | MP0002419_abnormal_innate_immunity | 0.47439299 |
| 87 | MP0001944_abnormal_pancreas_morphology | 0.41566974 |
| 88 | MP0001853_heart_inflammation | 0.40559714 |
| 89 | MP0003303_peritoneal_inflammation | 0.40292252 |
| 90 | MP0010234_abnormal_vibrissa_follicle | 0.38994408 |
| 91 | MP0003705_abnormal_hypodermis_morpholog | 0.37096201 |
| 92 | MP0000767_abnormal_smooth_muscle | 0.36939877 |
| 93 | MP0005535_abnormal_body_temperature | 0.36706259 |
| 94 | MP0001784_abnormal_fluid_regulation | 0.35665014 |
| 95 | MP0003635_abnormal_synaptic_transmissio | 0.35140768 |
| 96 | MP0002078_abnormal_glucose_homeostasis | 0.34637338 |
| 97 | MP0004197_abnormal_fetal_growth/weight/ | 0.33944598 |
| 98 | MP0008874_decreased_physiological_sensi | 0.33437639 |
| 99 | MP0003866_abnormal_defecation | 0.32040265 |
| 100 | MP0010771_integument_phenotype | 0.31758564 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Severe combined immunodeficiency (HP:0004430) | 9.75933111 |
| 2 | Thyroiditis (HP:0100646) | 9.49208207 |
| 3 | Panhypogammaglobulinemia (HP:0003139) | 9.19135762 |
| 4 | Eosinophilia (HP:0001880) | 8.47836655 |
| 5 | Combined immunodeficiency (HP:0005387) | 8.37760849 |
| 6 | Hypoproteinemia (HP:0003075) | 7.55605619 |
| 7 | Recurrent viral infections (HP:0004429) | 7.48646110 |
| 8 | Granulocytopenia (HP:0001913) | 6.82560673 |
| 9 | Abnormality of eosinophils (HP:0001879) | 6.15593319 |
| 10 | Abnormality of T cells (HP:0002843) | 5.60990077 |
| 11 | Erythroderma (HP:0001019) | 5.48866630 |
| 12 | Leukocytosis (HP:0001974) | 4.40978974 |
| 13 | IgG deficiency (HP:0004315) | 4.26767152 |
| 14 | Recurrent fungal infections (HP:0002841) | 4.08747270 |
| 15 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 3.37394826 |
| 16 | Abnormality of the thymus (HP:0000777) | 2.80970336 |
| 17 | Meningitis (HP:0001287) | 2.14012832 |
| 18 | Deep philtrum (HP:0002002) | 2.07246148 |
| 19 | T lymphocytopenia (HP:0005403) | 12.6232536 |
| 20 | Abnormality of T cell number (HP:0011839) | 11.9442229 |
| 21 | Abnormality of B cell number (HP:0010975) | 11.6564859 |
| 22 | B lymphocytopenia (HP:0010976) | 11.6564859 |
| 23 | Hypoplasia of the thymus (HP:0000778) | 11.1437956 |
| 24 | Cellular immunodeficiency (HP:0005374) | 1.99300992 |
| 25 | Abnormality of the fingertips (HP:0001211) | 1.97303907 |
| 26 | Sepsis (HP:0100806) | 1.96132339 |
| 27 | Volvulus (HP:0002580) | 1.89518802 |
| 28 | Bicuspid aortic valve (HP:0001647) | 1.87134696 |
| 29 | Lymphoma (HP:0002665) | 1.79823274 |
| 30 | Pustule (HP:0200039) | 1.79628563 |
| 31 | Acute lymphatic leukemia (HP:0006721) | 1.78039981 |
| 32 | Mitral regurgitation (HP:0001653) | 1.58764489 |
| 33 | Papilloma (HP:0012740) | 1.52097324 |
| 34 | Verrucae (HP:0200043) | 1.52097324 |
| 35 | Bronchiectasis (HP:0002110) | 1.51287692 |
| 36 | Hyperacusis (HP:0010780) | 1.46389222 |
| 37 | Macroorchidism (HP:0000053) | 1.45357226 |
| 38 | Supranuclear gaze palsy (HP:0000605) | 1.42680842 |
| 39 | Pruritus (HP:0000989) | 1.38626445 |
| 40 | Autoimmune thrombocytopenia (HP:0001973) | 1.34089493 |
| 41 | Basal cell carcinoma (HP:0002671) | 1.33269358 |
| 42 | Type 2 muscle fiber atrophy (HP:0003554) | 1.26901107 |
| 43 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.25804372 |
| 44 | Joint swelling (HP:0001386) | 1.23516708 |
| 45 | Aortic valve stenosis (HP:0001650) | 1.23006573 |
| 46 | Weak cry (HP:0001612) | 1.20253077 |
| 47 | Muscle fiber atrophy (HP:0100295) | 1.14226089 |
| 48 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.12768876 |
| 49 | Wide intermamillary distance (HP:0006610) | 1.12685684 |
| 50 | Slow saccadic eye movements (HP:0000514) | 1.10169666 |
| 51 | Nephrotic syndrome (HP:0000100) | 1.09945830 |
| 52 | Abnormality of chromosome segregation (HP:0002916) | 1.08536822 |
| 53 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.05543365 |
| 54 | Recurrent cutaneous fungal infections (HP:0011370) | 1.05543365 |
| 55 | Heterotopia (HP:0002282) | 1.02332264 |
| 56 | Sparse lateral eyebrow (HP:0005338) | 1.01950357 |
| 57 | Hypothyroidism (HP:0000821) | 0.98877515 |
| 58 | Broad palm (HP:0001169) | 0.96102741 |
| 59 | Decreased muscle mass (HP:0003199) | 0.95251593 |
| 60 | Increased nuchal translucency (HP:0010880) | 0.93315592 |
| 61 | Dry skin (HP:0000958) | 0.93004709 |
| 62 | Seborrheic dermatitis (HP:0001051) | 0.91228565 |
| 63 | Abnormality of the neuromuscular junction (HP:0003398) | 0.90967821 |
| 64 | Fatigable weakness (HP:0003473) | 0.90967821 |
| 65 | Cutis marmorata (HP:0000965) | 0.90485475 |
| 66 | Encephalitis (HP:0002383) | 0.89910499 |
| 67 | Abnormality of proline metabolism (HP:0010907) | 0.88708386 |
| 68 | Hydroxyprolinuria (HP:0003080) | 0.88708386 |
| 69 | Inappropriate behavior (HP:0000719) | 0.86685031 |
| 70 | Long eyelashes (HP:0000527) | 0.85058784 |
| 71 | Pseudobulbar signs (HP:0002200) | 0.84854530 |
| 72 | Generalized hypotonia (HP:0001290) | 0.84025859 |
| 73 | Spontaneous hematomas (HP:0007420) | 0.83575961 |
| 74 | Hypochromic anemia (HP:0001931) | 0.80703885 |
| 75 | Easy fatigability (HP:0003388) | 0.80189142 |
| 76 | Obsessive-compulsive behavior (HP:0000722) | 0.79233600 |
| 77 | Disinhibition (HP:0000734) | 0.79179027 |
| 78 | Abnormality of the pancreatic islet cells (HP:0006476) | 0.79131302 |
| 79 | Abnormality of endocrine pancreas physiology (HP:0012093) | 0.79131302 |
| 80 | Premature skin wrinkling (HP:0100678) | 0.78915153 |
| 81 | Abnormality of oral frenula (HP:0000190) | 0.78507512 |
| 82 | Increased IgM level (HP:0003496) | 0.74354556 |
| 83 | Prolonged bleeding time (HP:0003010) | 0.74225598 |
| 84 | Abnormal platelet volume (HP:0011876) | 0.73391544 |
| 85 | Tented upper lip vermilion (HP:0010804) | 0.73263353 |
| 86 | Hypochromic microcytic anemia (HP:0004840) | 0.71773126 |
| 87 | Proximal placement of thumb (HP:0009623) | 0.71754533 |
| 88 | Autoimmune hemolytic anemia (HP:0001890) | 0.70565906 |
| 89 | Vertebral arch anomaly (HP:0008438) | 0.70353516 |
| 90 | Elfin facies (HP:0004428) | 0.70267029 |
| 91 | Muscle stiffness (HP:0003552) | 0.69934524 |
| 92 | Hepatitis (HP:0012115) | 0.68557562 |
| 93 | Sacral dimple (HP:0000960) | 0.68473286 |
| 94 | Pancreatic islet-cell hyperplasia (HP:0004510) | 0.67852446 |
| 95 | Deep venous thrombosis (HP:0002625) | 0.67805637 |
| 96 | Abnormal foot bone ossification (HP:0010675) | 0.66721656 |
| 97 | Stomatitis (HP:0010280) | 0.66589595 |
| 98 | Truncal obesity (HP:0001956) | 0.66108683 |
| 99 | Recurrent skin infections (HP:0001581) | 0.65292006 |
| 100 | Chronic otitis media (HP:0000389) | 0.65099511 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | YES1 | 4.83984148 |
| 2 | PDGFRB | 3.84198755 |
| 3 | ZAP70 | 3.61374522 |
| 4 | MAP3K7 | 3.40435306 |
| 5 | MAP4K1 | 3.09856013 |
| 6 | GRK6 | 2.77557676 |
| 7 | SYK | 2.75128480 |
| 8 | SIK2 | 2.61757398 |
| 9 | TXK | 2.47671318 |
| 10 | MST4 | 2.36014663 |
| 11 | MARK2 | 2.30110667 |
| 12 | MAPK7 | 2.26595340 |
| 13 | ITK | 2.25844972 |
| 14 | CSNK1A1L | 2.17616465 |
| 15 | CSK | 2.13707940 |
| 16 | FGFR2 | 2.11769548 |
| 17 | CDK12 | 1.97835559 |
| 18 | MAP3K10 | 1.94828494 |
| 19 | PKN2 | 1.88407720 |
| 20 | CSNK1G3 | 1.69799057 |
| 21 | CAMKK2 | 1.68429729 |
| 22 | PRKCQ | 1.66886242 |
| 23 | CSNK1G2 | 1.59720151 |
| 24 | HCK | 1.59069414 |
| 25 | MAPK4 | 1.57346395 |
| 26 | NTRK2 | 1.52963854 |
| 27 | LCK | 1.51878610 |
| 28 | CAMK1 | 1.51502543 |
| 29 | FGFR4 | 1.46967224 |
| 30 | CDK6 | 1.45509975 |
| 31 | RIPK4 | 1.41705644 |
| 32 | PTK6 | 1.40544668 |
| 33 | STK10 | 1.31620960 |
| 34 | BRD4 | 1.25943070 |
| 35 | CSNK1G1 | 1.19624210 |
| 36 | FGFR3 | 1.18266350 |
| 37 | TYK2 | 1.18115139 |
| 38 | MAPK12 | 1.17289521 |
| 39 | TRIB3 | 1.15832313 |
| 40 | PRKCH | 1.13954021 |
| 41 | CAMKK1 | 1.13918639 |
| 42 | NEK2 | 1.10998813 |
| 43 | PRKD1 | 1.09242802 |
| 44 | INSR | 1.02912447 |
| 45 | HIPK2 | 0.98160669 |
| 46 | RPS6KB2 | 0.92216489 |
| 47 | DYRK1B | 0.92092773 |
| 48 | CDK3 | 0.91200053 |
| 49 | LRRK2 | 0.90520851 |
| 50 | UHMK1 | 0.89446894 |
| 51 | TYRO3 | 0.88917301 |
| 52 | MKNK2 | 0.88425981 |
| 53 | CLK1 | 0.87952004 |
| 54 | FYN | 0.80714950 |
| 55 | JAK2 | 0.76718441 |
| 56 | SIK1 | 0.69619644 |
| 57 | MAP3K1 | 0.69497918 |
| 58 | RET | 0.69360584 |
| 59 | STK4 | 0.64804502 |
| 60 | CDC7 | 0.61230526 |
| 61 | CDK4 | 0.59864553 |
| 62 | EPHB1 | 0.58523732 |
| 63 | PRKDC | 0.55947960 |
| 64 | PDGFRA | 0.53837599 |
| 65 | ALK | 0.51722558 |
| 66 | ERBB3 | 0.50613528 |
| 67 | CAMK4 | 0.49850947 |
| 68 | MAPK3 | 0.49778282 |
| 69 | MAPK11 | 0.48036983 |
| 70 | BTK | 0.47759415 |
| 71 | MAP3K13 | 0.47644419 |
| 72 | EGFR | 0.46334934 |
| 73 | MAPK9 | 0.45425256 |
| 74 | CSNK1D | 0.44454448 |
| 75 | PAK3 | 0.44239558 |
| 76 | TEC | 0.42184705 |
| 77 | MAPK8 | 0.41262244 |
| 78 | ATM | 0.39562091 |
| 79 | FGFR1 | 0.38763128 |
| 80 | CHEK1 | 0.38116746 |
| 81 | PRKD2 | 0.37910314 |
| 82 | ABL1 | 0.37585552 |
| 83 | SRC | 0.36539046 |
| 84 | SGK3 | 0.34741365 |
| 85 | ERN1 | 0.34112908 |
| 86 | TTN | 0.32780423 |
| 87 | EEF2K | 0.32099118 |
| 88 | DAPK2 | 0.30983182 |
| 89 | MKNK1 | 0.30542915 |
| 90 | MAP3K2 | 0.28488746 |
| 91 | TESK2 | 0.26208613 |
| 92 | GSK3B | 0.25617669 |
| 93 | MAPK14 | 0.25590739 |
| 94 | CDK2 | 0.24202870 |
| 95 | MAPKAPK2 | 0.23937299 |
| 96 | ATR | 0.23657217 |
| 97 | TNK2 | 0.23182803 |
| 98 | MAPK1 | 0.22426699 |
| 99 | FES | 0.21533284 |
| 100 | MAP3K8 | 0.21235317 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 4.97476166 |
| 2 | Non-homologous end-joining_Homo sapiens_hsa03450 | 4.06287356 |
| 3 | Antigen processing and presentation_Homo sapiens_hsa04612 | 3.64988033 |
| 4 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.61218171 |
| 5 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.30627237 |
| 6 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.15914013 |
| 7 | Primary immunodeficiency_Homo sapiens_hsa05340 | 10.5523242 |
| 8 | Thyroid cancer_Homo sapiens_hsa05216 | 1.86941643 |
| 9 | Circadian rhythm_Homo sapiens_hsa04710 | 1.52845448 |
| 10 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.52600053 |
| 11 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.45514285 |
| 12 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.42006821 |
| 13 | Lysine degradation_Homo sapiens_hsa00310 | 1.41095036 |
| 14 | FoxO signaling pathway_Homo sapiens_hsa04068 | 1.26856915 |
| 15 | Endometrial cancer_Homo sapiens_hsa05213 | 1.26369195 |
| 16 | Colorectal cancer_Homo sapiens_hsa05210 | 1.14978628 |
| 17 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.14882864 |
| 18 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.11490528 |
| 19 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.11456591 |
| 20 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.08629347 |
| 21 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.04292669 |
| 22 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.04031077 |
| 23 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.00603209 |
| 24 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.96550976 |
| 25 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.95058532 |
| 26 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.94362635 |
| 27 | Prostate cancer_Homo sapiens_hsa05215 | 0.90143027 |
| 28 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.88085991 |
| 29 | Long-term potentiation_Homo sapiens_hsa04720 | 0.82515202 |
| 30 | HTLV-I infection_Homo sapiens_hsa05166 | 0.82057674 |
| 31 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.81175482 |
| 32 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.73723347 |
| 33 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.69191382 |
| 34 | Platelet activation_Homo sapiens_hsa04611 | 0.68295960 |
| 35 | Melanogenesis_Homo sapiens_hsa04916 | 0.66447463 |
| 36 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.64444141 |
| 37 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.63345697 |
| 38 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.61752313 |
| 39 | Hepatitis B_Homo sapiens_hsa05161 | 0.60904348 |
| 40 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.56442020 |
| 41 | Measles_Homo sapiens_hsa05162 | 0.55215341 |
| 42 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.54195446 |
| 43 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.54124273 |
| 44 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.51850878 |
| 45 | Glioma_Homo sapiens_hsa05214 | 0.51010414 |
| 46 | Adherens junction_Homo sapiens_hsa04520 | 0.50995113 |
| 47 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.47601290 |
| 48 | Insulin resistance_Homo sapiens_hsa04931 | 0.46867402 |
| 49 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.46056703 |
| 50 | Renin secretion_Homo sapiens_hsa04924 | 0.45815730 |
| 51 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.44111379 |
| 52 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.43444115 |
| 53 | Spliceosome_Homo sapiens_hsa03040 | 0.43197560 |
| 54 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.42626933 |
| 55 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.42175188 |
| 56 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.41554971 |
| 57 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.40929159 |
| 58 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.39680928 |
| 59 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.39417322 |
| 60 | Pathways in cancer_Homo sapiens_hsa05200 | 0.38894614 |
| 61 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.38758101 |
| 62 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.38694337 |
| 63 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.38674154 |
| 64 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.38429243 |
| 65 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.37448463 |
| 66 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.37208463 |
| 67 | Viral myocarditis_Homo sapiens_hsa05416 | 0.36767590 |
| 68 | Salivary secretion_Homo sapiens_hsa04970 | 0.33873120 |
| 69 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.30731484 |
| 70 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.30731012 |
| 71 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.30449197 |
| 72 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.30439324 |
| 73 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.28273542 |
| 74 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.27017331 |
| 75 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.26781510 |
| 76 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.26118865 |
| 77 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.26058223 |
| 78 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.25068159 |
| 79 | Cell cycle_Homo sapiens_hsa04110 | 0.25051927 |
| 80 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.24951237 |
| 81 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.23529384 |
| 82 | ABC transporters_Homo sapiens_hsa02010 | 0.23158095 |
| 83 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.22921437 |
| 84 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.22442749 |
| 85 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.22133374 |
| 86 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.21380733 |
| 87 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.20219469 |
| 88 | Endocytosis_Homo sapiens_hsa04144 | 0.20054362 |
| 89 | Gap junction_Homo sapiens_hsa04540 | 0.19706623 |
| 90 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.19678470 |
| 91 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.19294131 |
| 92 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.19289767 |
| 93 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.19002672 |
| 94 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.18949262 |
| 95 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.18332455 |
| 96 | Leishmaniasis_Homo sapiens_hsa05140 | 0.16402163 |
| 97 | Bile secretion_Homo sapiens_hsa04976 | 0.15395630 |
| 98 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.15344467 |
| 99 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.14956535 |
| 100 | Axon guidance_Homo sapiens_hsa04360 | 0.14931982 |

